Switch to:
More From Other Websites
Panel: Painkiller training should be required for physicians May 04 2016
Panel: Painkiller training should be required for physicians May 04 2016
FDA advisers reconsider training for painkiller prescribers May 04 2016
J&J Loses Second Talcum Powder Cancer Case May 04 2016
St. Louis jury orders Johnson & Johnson to pay $55 million in talc case May 04 2016
Analyzing Future Estimates for Johnson & Johnson May 04 2016
Bank of America's 17 High-Quality Cash-Rich Stocks for Investors to Consider May 04 2016
Johnson & Johnson Faces Growing Threat of Lawsuits Over Talc and Cancer May 04 2016
Another big verdict in talc case against Johnson & Johnson May 03 2016
Another big verdict in talc case against Johnson & Johnson May 03 2016
Baby Powder Cancer Suits Cloud Johnson and Johnson May 03 2016
JNJ to Pay $55 Million in Ovarian Cancer Suit (JNJ) May 03 2016
[$$] Revlimid Continues Dominating Multiple Myeloma May 03 2016
Johnson & Johnson to pay $55M in second talc-powder cancer lawsuit May 03 2016
Pfizer tops Street 1Q forecasts on higher sales, lower taxes May 03 2016
Pfizer tops Street 1Q forecasts on higher sales, lower taxes May 03 2016
Johnson & Johnson faces $55M verdict in talc-powder trial May 03 2016
Johnson & Johnson loses another talcum powder cancer lawsuit May 03 2016
What women really want (hint: money talks) May 03 2016
Johnson & Johnson (JNJ) Stock Drops, Must Pay $55 Million in Talc-Powder Case May 03 2016
Johnson & Johnson Loses Another Court Case Over Claims Its Talcum Powder Causes Cancer May 03 2016
Stocks, dollar slide May 03 2016
Early movers: PFE, BIIB, TAP, CVS, MNK, IMS, CLX, COST & more May 03 2016
May's strong start may be wiped out on Wall Street May 03 2016
Talc powder firm to pay $55m to victim May 03 2016
Johnson & Johnson ordered to pay $55 million in talc-powder trial May 03 2016
Johnson & Johnson ordered to pay $55 million in talc-powder trial May 02 2016
Johnson & Johnson ordered to pay $55 million in talc-powder trial May 02 2016
Johnson & Johnson to Appeal Jury Verdict in Cosmetic Talc Trial May 02 2016
Johnson & Johnson ordered to pay $55 million in talc-powder trial May 02 2016
Johnson & Johnson ordered to pay $55 million in talc-powder trial May 02 2016
Johnson & Johnson ordered to pay $55 million in talc-powder trial May 02 2016
Janssen Submits Application to U.S. FDA Seeking Approval of a Mebendazole Chewable Tablet for the... Apr 29 2016
Correction: Abbott-St Jude Acquisition story Apr 29 2016
Johnson & Johnson hikes dividend at shareholders meeting Apr 28 2016
Johnson & Johnson Announces Dividend Increase of 6.7% Apr 28 2016
Johnson & Johnson Consumer Inc. to Acquire NeoStrata Company, Inc., a Leader in Dermocosmetics Apr 27 2016
Stung by low oil prices, Exxon loses 'AAA' rating from S&P Apr 26 2016
Johnson & Johnson Consumer Inc. to Acquire NeoStrata Company, Inc., a Leader in Dermocosmetics Apr 26 2016
If the 16-year rally in 'consumer staple' shares is ending, sell a little Fundsmith Apr 25 2016
Johnson & Johnson to Participate in the 2016 Deutsche Bank 41st Annual Health Care Conference Apr 21 2016
Asian stock indexes mixed; market focus on ECB remarks Apr 19 2016
Business Highlights Apr 19 2016
US STOCKS-Wall Street nears record as quarterly reports roll in Apr 19 2016
GLOBAL MARKETS-Oil gains on Kuwait strike; global shares highest since Dec Apr 19 2016
US STOCKS SNAPSHOT-Wall St inches closer to record on energy, earnings Apr 19 2016
US STOCKS-Wall St nears record terrain as quarterly reports roll in Apr 19 2016
Johnson & Johnson rides strong prescription sales in 1Q Apr 19 2016
J&J shares hit new high on strong drug sales, weaker dollar Apr 19 2016
J&J shares hit new high on strong drug sales, weaker dollar Apr 19 2016
Global Public-Private Partnership Announces Publication of Positive Phase 1 Data for Ebola Vaccine... Apr 19 2016
Johnson & Johnson Reports 2016 First-Quarter Results Apr 19 2016
Johnson & Johnson tops 1Q forecasts Apr 19 2016
Johnson & Johnson Reports 2016 First-Quarter Results: Apr 19 2016
Mothers and Families for Global Change Join Forces for Fourth Annual Moms +SocialGood on May 5, 2016... Apr 06 2016
Johnson & Johnson Announces Launch of New Global Public Health Strategy at Opening of New Operations... Apr 05 2016
Janssen Announces Discontinuation of Fulranumab Phase 3 Development Program in Osteoarthritis Pain Mar 31 2016
Johnson & Johnson to Webcast Annual Meeting of Shareholders Mar 28 2016
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results Mar 23 2016
Business Highlights Mar 22 2016
J&J expands project that aims to predict, prevent diseases Mar 22 2016
UK cost agency backs J&J cancer drug in change of heart Mar 21 2016
UK cost agency backs J&J cancer drug in change of heart Mar 21 2016
J Walter Thompson CEO quits after being accused of slurs Mar 17 2016
Johnson & Johnson hit with $500 million verdict in hip implant trial Mar 17 2016
Johnson & Johnson hit with $500 million verdict in hip implant trial Mar 17 2016
Johnson & Johnson hit with $500 million verdict in hip implant trial Mar 17 2016
Johnson & Johnson Innovation Launches JLINX: A New Company Incubation Model Located at the Janssen... Mar 16 2016
Top ad exec freely uses racist, sexist slurs -NY lawsuit Mar 11 2016
Top ad exec freely uses racist, sexist slurs -NY lawsuit Mar 10 2016
UK cost agency rejects leukaemia drug from J&J and AbbVie Mar 01 2016
J&J To Pay $72m Over Talc-Linked Cancer Death Feb 23 2016
US company tests possible diabetes cure Feb 04 2016
The Institute of Cancer Research, London Sells a Portion of Its Royalty Entitlement Relating to... Feb 02 2016
CCI approval_Johnson & Johnson Jan 28 2016
US STOCKS-Oil fuels 'schizophrenic' rebound on Wall Street Jan 26 2016
US STOCKS-Oil fuels 'schizophrenic' rebound on Wall Street Jan 26 2016
US STOCKS SNAPSHOT-Wall Street rebounds, helped by oil, earnings Jan 26 2016
US STOCKS-Wall St jumps in 'schizophrenic' rebound fueled by oil Jan 26 2016
Johnson & Johnson Reports 2015 Fourth-Quarter Results Jan 26 2016
GSK, Astra, J&J link with universities in new drug research fund Jan 25 2016
AstraZeneca buys most of Acerta for $4 bln to add cancer drug Dec 17 2015
MOVES-Barclays makes new appointments in healthcare banking group Dec 15 2015
MOVES-Barclays makes new appointments in healthcare banking group Dec 15 2015
FBI probing what J&J knew about uterine surgery device - WSJ May 27 2015
Interview - New-look GSK bets on consumer health spending May 06 2015
J&J cuts full-year forecast due to strong dollar Apr 14 2015
Johnson & Johnson buys energy drink brand in India Nov 07 2014


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK